Skip to content

Insmed

US · INSM #794 by market cap Listed 1970
141.33 -3.13 -2.17%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
C
Momentum strategy signal
Sell
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 1 upgrade vs 0 downgrades among tracked analyst rating changes.
  • Most recent: Morgan Stanley moved from Hold to Buy on 2026-03-30.

Analyst consensus 16 analysts

Buy
Avg price target 191.07 +35.2%
Price target rangecurrent 141.33
Low158.00
Avg191.07
High220.00
Buy 94% Hold 6% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-20 BofA Securities -- Buy 205.00
2026-11-19 Mizuho Securities -- Buy 158.00
2026-11-19 Raymond James -- Buy --
2026-11-19 BofA Securities -- Buy 205.00
2026-11-19 Guggenheim -- Buy 201.00
2026-11-17 RBC Capital -- Buy 195.00
2026-11-13 Morgan Stanley -- Buy 213.00
2026-11-05 Evercore -- Buy 170.00
2026-11-04 H.C. Wainwright -- Buy 220.00
2026-11-03 Mizuho Securities -- Buy 158.00
2026-11-02 BMO Capital -- Buy 192.00
2026-11-02 Barclays -- Buy 207.00
2026-11-01 Guggenheim -- Buy 201.00
2026-10-30 UBS -- Buy 172.00
2026-10-30 Morgan Stanley -- Buy 213.00
2026-10-30 BMO Capital -- Buy 192.00
2026-10-30 Goldman Sachs -- Buy 194.00
2026-10-29 Mizuho Securities -- Buy 154.00
2026-10-29 Roth MKM -- Buy 204.00
2026-10-29 RBC Capital -- Buy 195.00
2026-10-21 Morgan Stanley -- Buy 213.00
2026-10-20 Raymond James -- Buy 173.00
2026-10-20 Roth MKM -- Buy 198.00
2026-10-13 Wells Fargo -- Buy 169.00
2026-10-12 Wolfe Research -- Hold --

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-03-30 Morgan Stanley Hold → Buy 212.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-10-29 -- ±15.78% +15.07% (in line)
2026/Q2 2026-08-06 -- ±13.43% +33.86% (beat)
2026/Q1 2026-05-07 -- ±11.12% -23.41% (beat)
2025/Q4 2026-02-19 -- ±6.53% +6.54% (beat)
2025/Q3 2025-10-30 -- ±9.58% +16.33% (beat)
2025/Q2 2025-08-07 -- ±11.27% -1.76% (in line)
2025/Q1 2025-05-08 -- ±12.74% -3.88% (in line)
2024/Q4 2025-02-20 -- ±6.45% -0.26% (in line)
2024/Q3 2024-10-31 -- ±9.82% -4.29% (in line)
2024/Q2 2024-08-08 -- ±10.20% +1.16% (in line)
2024/Q1 2024-05-09 -- ±21.80% +1.46% (in line)
2023/Q4 2024-02-22 -- ±11.03% -3.86% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:34 · For reference only, not investment advice and not tailored to your situation.

Insmed discussion 0 comments

Add a comment